Search





Search





Markets
/
Stocks
/
glue
/

Monte Rosa Therapeutics Inc

GLUE

Add to Watchlist

16.520USD

-6.160-27.16%

Close 07-31 16:00（ET）Quotes delayed by 15 min

1.40BMarket Cap

LossP/E TTM

Monte Rosa Therapeutics Inc

16.520

-6.160-27.16%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

GLUE Balance Sheet

You can check out the annual or quarterly balance sheets of Monte Rosa Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

Total equity

Cash, cash equivalents and short-term investments

104.32%666.22M

1.33%377.10M

61.55%391.26M

10.83%290.59M

69.04%326.07M

60.12%372.15M

35.70%242.19M

29.12%262.20M

-16.76%192.89M

-11.57%232.41M

-34.42%178.48M

-30.96%203.07M

-26.94%231.73M

-24.05%262.83M

-25.85%272.15M

-17.62%294.14M

88.30%317.16M

--346.07M

--367.03M

--357.06M

--168.44M

- Cash and cash equivalents

103.56%159.86M

-42.08%129.88M

65.91%208.34M

-36.21%69.43M

-21.27%78.53M

75.06%224.25M

112.64%125.58M

131.46%108.85M

92.40%99.75M

133.28%128.10M

-47.46%59.05M

-54.64%47.03M

-62.51%51.85M

-84.13%54.91M

-69.38%112.39M

-70.97%103.66M

-17.89%138.31M

--346.07M

--367.03M

--357.06M

--168.44M

-Short-term investments

104.55%506.36M

67.16%247.22M

56.86%182.91M

44.21%221.16M

165.78%247.54M

41.78%147.90M

-2.35%116.61M

-1.72%153.36M

-48.22%93.14M

-49.83%104.31M

-25.25%119.42M

-18.08%156.04M

0.58%179.89M

--207.91M

--159.75M

--190.48M

--178.86M

----

Receivables

227.34%4.61M

6605.20%11.60M

734.45%4.96M

-75.92%2.37M

134.28%1.41M

-65.74%173.00K

102.38%595.00K

752.86%9.84M

-72.30%601.00K

-93.40%505.00K

-98.33%294.00K

--1.15M

--2.17M

--7.66M

--17.56M

----

-Accounts and notes receivable

--0.00

--7.00M

----

--9.00M

----

-Other receivables

227.34%4.61M

2558.96%4.60M

734.45%4.96M

181.47%2.37M

134.28%1.41M

-65.74%173.00K

102.38%595.00K

-27.04%842.00K

-72.30%601.00K

-93.40%505.00K

-98.33%294.00K

--1.15M

--2.17M

--7.66M

--17.56M

----

Prepaid expenses

40.02%6.72M

-12.45%4.48M

-33.61%5.59M

11.15%6.50M

-13.44%4.80M

55.37%5.12M

103.53%8.43M

50.59%5.85M

-2.62%5.54M

-25.88%3.29M

-9.39%4.14M

33.93%3.88M

77.71%5.69M

71.25%4.44M

31.10%4.57M

135.96%2.90M

-2.08%3.20M

--2.59M

--3.48M

--1.23M

--3.27M

Other current assets

--0.00

----

-100.00%0.00

--0.00

--960.00K

----

Total current assets

103.91%677.55M

4.17%393.19M

59.95%401.82M

7.76%299.46M

66.94%332.28M

59.79%377.44M

37.34%251.21M

33.54%277.90M

-17.26%199.04M

-14.38%236.21M

-38.05%182.91M

-29.94%208.10M

-24.91%240.56M

-20.87%275.89M

-20.32%295.24M

-17.09%297.05M

86.58%320.37M

--348.67M

--370.52M

--358.29M

--171.71M

Non-current assets

Net Fixed Assets

-4.49%53.10M

-10.55%50.37M

-10.45%52.66M

-10.50%54.73M

-10.98%55.60M

-10.06%56.31M

-8.69%58.81M

-6.93%61.14M

-2.10%62.46M

1.14%62.61M

11.19%64.40M

5.44%65.69M

214.19%63.80M

402.29%61.91M

390.79%57.92M

598.27%62.31M

162.62%20.31M

--12.32M

--11.80M

--8.92M

--7.73M

-Fixed Assets

7.60%82.75M

1.70%77.98M

1.40%78.19M

1.05%78.16M

0.40%76.90M

2.44%76.68M

3.09%77.11M

4.15%77.34M

7.58%76.60M

9.83%74.86M

18.54%74.80M

11.71%74.26M

201.90%71.20M

353.54%68.16M

360.67%63.10M

547.02%66.47M

173.77%23.59M

--15.03M

--13.70M

--10.27M

--8.62M

-Accumulated depreciation

39.14%29.64M

35.60%27.61M

39.44%25.52M

44.62%23.43M

50.66%21.30M

66.32%20.36M

76.03%18.30M

89.16%16.20M

91.04%14.14M

95.87%12.24M

100.73%10.40M

105.47%8.56M

125.74%7.40M

131.26%6.25M

173.21%5.18M

208.51%4.17M

271.35%3.28M

--2.70M

--1.90M

--1.35M

--883.00K

Other non-current assets

8.63%5.78M

2.49%5.10M

5.80%5.36M

6.31%5.39M

1.29%5.32M

0.93%4.98M

5.74%5.07M

5.33%5.08M

12.41%5.25M

7.31%4.93M

7.69%4.79M

-15.53%4.82M

-12.39%4.67M

-13.90%4.60M

157.37%4.45M

229.90%5.70M

358.16%5.33M

--5.34M

--1.73M

--1.16M

Total non-current assets

-3.35%58.88M

-9.49%55.47M

-9.16%58.02M

-9.21%60.12M

-10.03%60.92M

-9.25%61.29M

-7.69%63.87M

-6.09%66.22M

-1.11%67.71M

1.56%67.54M

10.94%69.19M

3.68%70.51M

167.06%68.47M

276.51%66.50M

360.96%62.37M

538.48%68.01M

188.21%25.64M

--17.66M

--13.53M

--10.65M

--8.90M

Total assets

87.29%736.43M

2.26%448.66M

45.94%459.84M

4.50%359.59M

47.41%393.20M

44.44%438.73M

24.98%315.08M

23.51%344.11M

-13.68%266.75M

-11.28%303.75M

-29.50%252.10M

-23.68%278.62M

-10.69%309.03M

-6.54%342.39M

-6.89%357.60M

-1.05%365.06M

91.58%346.00M

--366.33M

--384.05M

--368.94M

--180.60M

Liabilities

Current liabilities

-Other payables

-100.00%0.00

--0.00

--1.65M

--1.51M

--4.42M

----

--0.00

----

Accrued expenses

57.14%25.59M

42.10%26.69M

18.56%17.90M

7.90%13.77M

52.03%16.29M

28.66%18.79M

6.12%15.10M

14.80%12.76M

4.59%10.71M

0.14%14.60M

58.58%14.23M

42.18%11.11M

58.68%10.24M

44.64%14.58M

-2.62%8.97M

134.89%7.82M

265.72%6.46M

--10.08M

--9.21M

--3.33M

--1.77M

Deferred liabilities

1.49%33.06M

-74.78%29.57M

31.04%24.79M

-6.29%18.41M

59.63%32.58M

563.15%117.23M

--18.92M

--19.64M

--20.41M

--17.68M

----

Other current liabilities

1.49%33.06M

-74.78%29.57M

31.04%24.79M

-6.29%18.41M

59.63%32.58M

563.15%117.23M

--18.92M

--19.64M

--20.41M

--17.68M

----

--0.00

----

Total current liabilities

19.96%71.04M

-59.09%64.21M

47.55%61.44M

-1.17%41.85M

43.40%59.22M

236.85%156.95M

84.18%41.64M

121.85%42.35M

101.28%41.29M

82.22%46.59M

3.76%22.61M

29.22%19.09M

64.25%20.52M

53.68%25.57M

71.00%21.79M

36.90%14.77M

37.39%12.49M

--16.64M

--12.74M

--10.79M

--9.09M

Non-current liabilities

Long-term provisions

32.79%5.26M

42.22%5.26M

67.91%4.74M

74.37%4.56M

54.24%3.96M

36.45%3.70M

94.29%2.82M

73.69%2.61M

69.84%2.57M

76.97%2.71M

-31.72%1.45M

-29.61%1.50M

-30.74%1.51M

-29.55%1.53M

6.35%2.13M

45.24%2.14M

128.35%2.18M

--2.18M

--2.00M

--1.47M

--956.00K

Long-term debt and lease liabilities

-8.99%34.58M

-10.79%34.79M

-10.30%35.93M

-9.41%37.04M

-9.17%38.00M

-9.04%39.00M

-7.96%40.05M

-7.85%40.88M

-3.32%41.84M

-2.27%42.88M

2.17%43.52M

-3.75%44.37M

693.02%43.27M

--43.87M

--42.59M

--46.09M

--5.46M

--0.00

-Long-term lease liabilities

-8.99%34.58M

-10.79%34.79M

-10.30%35.93M

-9.41%37.04M

-9.17%38.00M

-9.04%39.00M

-7.96%40.05M

-7.85%40.88M

-3.32%41.84M

-2.27%42.88M

2.17%43.52M

-3.75%44.37M

693.02%43.27M

--43.87M

--42.59M

--46.09M

--5.46M

----

Deferred liabilities

514.57%103.64M

589.49%111.33M

345.67%111.89M

-76.01%8.06M

-40.89%16.86M

-50.04%16.15M

--25.11M

--33.60M

--28.53M

--32.32M

----

Employee benefits

32.79%5.26M

42.22%5.26M

67.91%4.74M

74.37%4.56M

54.24%3.96M

36.45%3.70M

94.29%2.82M

73.69%2.61M

69.84%2.57M

76.97%2.71M

-31.72%1.45M

-29.61%1.50M

-30.74%1.51M

-29.55%1.53M

6.35%2.13M

45.24%2.14M

128.35%2.18M

--2.18M

--2.00M

--1.47M

--956.00K

Other non-current liabilities

422.93%108.89M

487.42%116.60M

317.59%116.63M

-65.16%12.62M

-33.04%20.82M

-43.35%19.85M

1822.23%27.93M

2305.98%36.21M

1956.68%31.10M

2185.45%35.04M

-31.72%1.45M

-29.61%1.50M

-30.74%1.51M

-29.55%1.53M

6.35%2.13M

45.24%2.14M

128.35%2.18M

--2.18M

--2.00M

--1.47M

--956.00K

Total non-current liabilities

143.91%143.48M

157.25%151.39M

124.41%152.56M

-35.59%49.65M

-19.35%58.82M

-24.47%58.85M

51.17%67.98M

68.06%77.09M

62.85%72.93M

71.59%77.91M

0.56%44.97M

-4.89%45.87M

486.22%44.79M

1986.72%45.41M

2134.93%44.72M

3176.70%48.23M

699.16%7.64M

--2.18M

--2.00M

--1.47M

--956.00K

Total liabilities

81.73%214.51M

-0.09%215.60M

95.22%214.00M

-23.39%91.51M

3.34%118.04M

73.32%215.80M

62.21%109.62M

83.87%119.44M

74.92%114.23M

75.42%124.50M

1.61%67.58M

3.10%64.96M

224.40%65.30M

277.25%70.98M

351.11%66.51M

413.79%63.01M

100.36%20.13M

--18.81M

--14.74M

--12.26M

--10.05M

Shareholders' equity

Common equity

56.43%1.05B

7.40%714.10M

3.09%680.16M

3.04%675.45M

21.18%670.19M

21.36%664.88M

27.22%659.80M

27.77%655.51M

8.94%553.07M

8.77%547.86M

5.10%518.62M

7.57%513.05M

7.11%507.69M

6.81%503.70M

5.02%493.45M

9.18%476.94M

72042.31%473.98M

--471.57M

--469.85M

--436.85M

--657.00K

Retained earnings

-33.19%-521.72M

-8.81%-477.21M

4.63%-431.08M

5.64%-404.00M

1.55%-391.70M

-19.87%-438.59M

-35.89%-452.02M

-43.80%-428.17M

-51.52%-397.86M

-58.71%-365.89M

-66.52%-332.64M

-72.67%-297.75M

-79.89%-262.57M

-88.91%-230.54M

-102.60%-199.75M

-118.94%-172.44M

-141.86%-145.97M

---122.03M

---98.59M

---78.76M

---60.35M

Capital reserves

56.43%1.05B

7.40%714.09M

3.09%680.16M

3.04%675.45M

21.18%670.19M

21.36%664.87M

27.22%659.80M

27.77%655.50M

8.94%553.06M

8.77%547.86M

5.10%518.61M

7.57%513.04M

7.11%507.69M

6.81%503.70M

5.02%493.44M

9.18%476.94M

72151.52%473.97M

--471.57M

--469.85M

--436.85M

--656.00K

Gains losses not affecting retained earnings

-42.57%-4.75M

-14.03%-3.83M

-39.84%-3.25M

-26.33%-3.37M

-23.62%-3.33M

-23.20%-3.36M

-59.59%-2.32M

-62.80%-2.67M

-93.32%-2.69M

-55.48%-2.72M

44.08%-1.46M

33.28%-1.64M

34.69%-1.39M

13.31%-1.75M

-33.44%-2.60M

-73.71%-2.46M

-131.85%-2.13M

---2.02M

---1.95M

---1.42M

---920.00K

Total equity

89.68%521.92M

4.54%233.06M

19.65%245.84M

19.32%268.08M

80.41%275.16M

24.37%222.94M

11.34%205.46M

5.16%224.67M

-37.42%152.52M

-33.96%179.25M

-36.61%184.52M

-29.27%213.65M

-25.21%243.73M

-21.90%271.41M

-21.18%291.09M

-15.32%302.05M

91.07%325.88M

--347.51M

--369.31M

--356.68M

--170.56M

Currency unit

--USD

Audit opinions

----

FAQs

Which balance sheet metrics matter most when analyzing GLUE stock?



Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?



Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?



Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does Monte Rosa Therapeutics Inc Have?



In its most recent quarterly, Monte Rosa Therapeutics Inc had 159.86M in cash and cash equivalents.

How Much Are Monte Rosa Therapeutics Inc's Total Liabilities?



Monte Rosa Therapeutics Inc reported 215.60M in total liabilities as of the latest reported quarter, including 64.21M in current liabilities and 151.39M in non-current liabilities.

What Are Monte Rosa Therapeutics Inc's Total Assets?



As of the latest reported quarter, Monte Rosa Therapeutics Inc's total assets were 448.66M, consisting of 393.19M in current assets and 55.47M in non-current assets.

How Much Shareholders' Equity Does Monte Rosa Therapeutics Inc Have?



Monte Rosa Therapeutics Inc reported 233.06M in total shareholders' equity as of the latest reported quarter.